PR Inside (Pressemitteilung) | Mon, Oct 26
Mon, Oct 26
OTTAWA, ONTARIO -- (Marketwire) -- 10/27/09 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") is pleased to announce highly positive results from the United States National Cancer Institute ("NCI") 5-dose in vitro anti-cancer screen of PharmaGap dr...
From PR Inside (Pressemitteilung):